Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (94)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishimura, K.
Right arrow Articles by Oga, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishimura, K.
Right arrow Articles by Oga, T.
(Chest. 2002;121:1434-1440.)
© 2002 American College of Chest Physicians

Dyspnea Is a Better Predictor of 5-Year Survival Than Airway Obstruction in Patients With COPD*

Koichi Nishimura, MD; Takateru Izumi, MD, FCCP; Mitsuhiro Tsukino, MD and Toru Oga, MD; on Behalf of the Kansai COPD Registry and Research Group in Japan

* From the Respiratory Division (Drs. Nishimura and Oga), Kyoto-Katsura Hospital, and the Department of Respiratory Medicine (Drs. Izumi and Tsukino), Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Correspondence to: Koichi Nishimura, MD, Respiratory Division, Kyoto-Katsura Hospital, 17 Yamadahirao, Nishikyo-Ku, Kyoto, 615-8256, Japan; e-mail: koichi-nishimura{at}nifty.ne.jp

Background: FEV1 is regarded as the most significant correlate of survival in COPD and is used as a measure of disease severity in the staging of COPD. Recently, however, the categorization of patients with COPD on the basis of the level of dyspnea has similarly been reported to be useful in the prediction of health-related quality of life and improvement in exercise performance after pulmonary rehabilitation.

Study objectives: We compared the effects of the level of dyspnea and disease severity, as evaluated by airway obstruction, on the 5-year survival rate of patients with COPD.

Design and methods: A total of 227 patients with COPD were enrolled in a 5-year, prospective, multicenter study in the Kansai area of Japan, involving 20 divisions of respiratory medicine from various university and city hospitals.

Results: After 5 years, 183 patients were available for the follow-up examination (follow-up rate, 81%). The 5-year cumulative survival rate among patients with COPD was 73%. The effect of disease staging, based on the American Thoracic Society (ATS) guideline as evaluated by the percentage of predicted FEV1, on the 5-year survival rate was not significant (p = 0.08). However, the level of dyspnea was significantly correlated to the 5-year survival rate (p < 0.001). The Cox proportional hazards model revealed that the level of dyspnea had a more significant effect on survival than disease severity based on FEV1.

Conclusions: The categorization of patients with COPD on the basis of the level of dyspnea was more discriminating than staging of disease severity using the ATS guideline with respect to 5-year survival. Dyspnea should be included as one of the variables, in addition to airway obstruction, for evaluating patients with COPD in terms of mortality.

Key Words: airway obstruction • categorization • COPD • dyspnea • mortality




This article has been cited by other articles:


Home page
ChestHome page
B. R. Celli
Update on the Management of COPD
Chest, June 1, 2008; 133(6): 1451 - 1462.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. G. Cote, V. Pinto-Plata, K. Kasprzyk, L. J. Dordelly, and B. R. Celli
The 6-Min Walk Distance, Peak Oxygen Uptake, and Mortality in COPD
Chest, December 1, 2007; 132(6): 1778 - 1785.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
V. M. Pinto-Plata, R. A. Celli-Cruz, C. Vassaux, L. Torre-Bouscoulet, A. Mendes, J. Rassulo, and B. R. Celli
Differences in Cardiopulmonary Exercise Test Results by American Thoracic Society/European Respiratory Society-Global Initiative for Chronic Obstructive Lung Disease Stage Categories and Gender
Chest, October 1, 2007; 132(4): 1204 - 1211.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. A. Mahler, L. A. Waterman, J. Ward, C. McCusker, R. ZuWallack, and J. C. Baird
Validity and Responsiveness of the Self-Administered Computerized Versions of the Baseline and Transition Dyspnea Indexes
Chest, October 1, 2007; 132(4): 1283 - 1290.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. G. Cote, L. J. Dordelly, and B. R. Celli
Impact of COPD Exacerbations on Patient-Centered Outcomes
Chest, March 1, 2007; 131(3): 696 - 704.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. L. P. Albuquerque, L. E. Nery, D. S. Villaca, T. Y. S. Machado, C. C. Oliveira, A. T. Paes, and J. A. Neder
Inspiratory fraction and exercise impairment in COPD patients GOLD stages II-III
Eur. Respir. J., November 1, 2006; 28(5): 939 - 944.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
C. Esteban, J.M. Quintana, M. Aburto, J. Moraza, and A. Capelastegui
A simple score for assessing stable chronic obstructive pulmonary disease
QJM, November 1, 2006; 99(11): 751 - 759.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
B. R. Celli
Roger S. Mitchell Lecture. Chronic Obstructive Pulmonary Disease Phenotypes and Their Clinical Relevance
Proceedings of the ATS, August 1, 2006; 3(6): 461 - 465.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
D. A. Mahler
Mechanisms and Measurement of Dyspnea in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, May 1, 2006; 3(3): 234 - 238.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
P. M. A. Calverley
Dynamic Hyperinflation: Is It Worth Measuring?
Proceedings of the ATS, May 1, 2006; 3(3): 239 - 244.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J. P. de Torres, E. Cordoba-Lanus, C. Lopez-Aguilar, M. Muros de Fuentes, A. Montejo de Garcini, A. Aguirre-Jaime, B. R. Celli, and C. Casanova
C-reactive protein levels and clinically important predictive outcomes in stable COPD patients
Eur. Respir. J., May 1, 2006; 27(5): 902 - 907.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. M. Mannino, M. M. Reichert, and K. J. Davis
Lung Function Decline and Outcomes in an Adult Population
Am. J. Respir. Crit. Care Med., May 1, 2006; 173(9): 985 - 990.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. W. Jones and A. G. N. Agusti
Outcomes and markers in the assessment of chronic obstructive pulmonary disease.
Eur. Respir. J., April 1, 2006; 27(4): 822 - 832.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
B. R. Celli
Change in the BODE index reflects disease modification in COPD: lessons from lung volume reduction surgery.
Chest, April 1, 2006; 129(4): 835 - 836.
[Full Text] [PDF]


Home page
ChestHome page
S. Imfeld, K. E. Bloch, W. Weder, and E. W. Russi
The BODE Index After Lung Volume Reduction Surgery Correlates With Survival.
Chest, April 1, 2006; 129(4): 873 - 878.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. E. O'Donnell
Is Sustained Pharmacologic Lung Volume Reduction Now Possible in COPD?
Chest, March 1, 2006; 129(3): 501 - 503.
[Full Text] [PDF]


Home page
ThoraxHome page
J J Soler-Cataluna, M A Martinez-Garcia, P Roman Sanchez, E Salcedo, M Navarro, and R Ochando
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
Thorax, November 1, 2005; 60(11): 925 - 931.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
C. G. Cote and B. R. Celli
Pulmonary rehabilitation and the BODE index in COPD
Eur. Respir. J., October 1, 2005; 26(4): 630 - 636.
[Abstract] [Full Text] [PDF]


Home page
Chronic Respiratory DiseaseHome page
N F Schlecht, K Schwartzman, and J Bourbeau
Dyspnea as clinical indicator in patients with chronic obstructive pulmonary disease
Chronic Respiratory Disease, October 1, 2005; 2(4): 183 - 191.
[Abstract] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. Casanova, C. Cote, J. P. de Torres, A. Aguirre-Jaime, J. M. Marin, V. Pinto-Plata, and B. R. Celli
Inspiratory-to-Total Lung Capacity Ratio Predicts Mortality in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 591 - 597.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. D. Nathan
Lung Transplantation: Disease-Specific Considerations for Referral
Chest, March 1, 2005; 127(3): 1006 - 1016.
[Abstract] [Full Text] [PDF]


Home page
Evid. Based Med.Home page
J. A Golish
The BODE index predicted death in chronic obstructive pulmonary disease
Evid. Based Med., September 1, 2004; 9(5): 156 - 156.
[Full Text] [PDF]


Home page
Eur Respir JHome page
B.R. Celli, W. MacNee, A. Agusti, A. Anzueto, B. Berg, A.S. Buist, P.M.A. Calverley, N. Chavannes, T. Dillard, B. Fahy, et al.
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
Eur. Respir. J., June 1, 2004; 23(6): 932 - 946.
[Full Text] [PDF]


Home page
NEJMHome page
B. R. Celli, C. G. Cote, J. M. Marin, C. Casanova, M. Montes de Oca, R. A. Mendez, V. Pinto Plata, and H. J. Cabral
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., March 4, 2004; 350(10): 1005 - 1012.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. I. Parekh, J. A. Blumenthal, M. A. Babyak, K. Merrill, R. M. Carney, R. D. Davis, and S. M. Palmer
Psychiatric Disorder and Quality of Life in Patients Awaiting Lung Transplantation
Chest, November 1, 2003; 124(5): 1682 - 1688.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. Oga, K. Nishimura, M. Tsukino, S. Sato, and T. Hajiro
Analysis of the Factors Related to Mortality in Chronic Obstructive Pulmonary Disease: Role of Exercise Capacity and Health Status
Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 544 - 549.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American College of Chest Physicians.